Source: Business Wire

Press Release: ApoCell : Emerging Liquid Biopsy Market: Technology & Market Forecast 2016-2020 - The Quest for Developing Clinically Actionable Liquid Biopsy Tests Has Just Started - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gjnc6f/emerging_liquid) has announced the addition of the "Emerging Liquid Biopsy Market: Technology & Market Forecast - 2016 Edition" report to their offering. Recent advances in genotyping and sequencing technologies are turning liquid biopsies into a clinically viable alternative to tissue biopsies, the current gold standard for making treatment decisions. As research validates the ability of liquid

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Darren W. Davis's photo - President & CEO of ApoCell

President & CEO

Darren W. Davis

CEO Approval Rating

86/100

Read more